Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Am J Obstet Gynecol ; 163(5 Pt 1): 1503-5, 1990 Nov.
Article in English | MEDLINE | ID: mdl-2240096

ABSTRACT

Hemoperitoneum as a result of coital injury without associated vaginal injury is an extremely rare entity, and evidence by only five cases that have been reported in the medical literature to date. We report five additional cases encountered in two medical centers. Two of these were ruptured corpus luteum cysts, one was a laceration of the round ligament, another was a laceration of an ovary, and the fifth was rupture of a serous cystadenoma. This diagnosis should be considered in patients with hemoperitoneum after coitus.


Subject(s)
Coitus , Hemoperitoneum/etiology , Vagina/injuries , Adult , Cystadenoma/pathology , Female , Humans , Ligaments/injuries , Ovarian Cysts/pathology , Ovarian Neoplasms/pathology , Ovary/injuries , Rupture , Uterus
2.
Obstet Gynecol ; 72(3 Pt 2): 459-61, 1988 Sep.
Article in English | MEDLINE | ID: mdl-3043294

ABSTRACT

Cyclosporine A has recently been reported to be an effective immunosuppressant agent for use in renal allograft recipients. Questions have been raised regarding its effects during pregnancy, in light of an increased life span and return of fertility in renal transplant patients. A preterm delivery is reported in a cadaveric renal allograft recipient chronically immunosuppressed with cyclosporine A and methylprednisolone. Dizygotic twins were delivered at 35 weeks' gestation, weighing 2452 and 2386 g. Maternal cyclosporine A levels were determined weekly by whole blood radioimmunoassay, with little increase in requirement found before delivery. No indication of maternal renal compromise was apparent, as evidenced by stable weekly creatinine clearance studies. Cyclosporine A, at the doses used, was passed transplacentally, with cord blood values of 34 and 57% of the maternal cyclosporine A level found at delivery. No adverse effects were noted at birth in the average for gestational age neonates, nor at nine-month follow-up evaluation. Given careful monitoring, cyclosporine A may be an effective immunosuppressant agent for use in pregnancies complicated by renal transplantation.


Subject(s)
Cyclosporins/therapeutic use , Kidney Transplantation , Pregnancy, Multiple/drug effects , Adult , Female , Humans , Infant, Newborn , Male , Methylprednisolone/therapeutic use , Pregnancy , Twins, Dizygotic
SELECTION OF CITATIONS
SEARCH DETAIL
...